retatrutide triple hormone receptor agonist retatrutide for diabetes type 2 metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial is gaining attention in – Lilly's triple agonist, retatrutide, delivered
Pay in 4 interest-free payments of $5.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5












:max_bytes(150000):strip_icc()/health-GettyImages-1340013135-64ee8863eb944cb2a0c308eee92f5bd2.jpg)












